RCS - Dechra Pharmaceutcls - Holding(s) in Company

Dechra PharmaceuticalsAnnouncement

18/01/2024 11:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240118:nRSR1670Aa&default-theme=true

RNS Number : 1670A  Dechra Pharmaceuticals PLC  18 January 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Bank of America Corporation

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the
notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

16-Jan-2024

6. Date on which Issuer notified

17-Jan-2024

7. Total positions of person(s) subject to the notification obligation

                                                                            % of voting rights attached to shares (total of 8.A)  % of voting rights through financial instruments (total of 8.B 1 + 8.B 2)  Total of both in % (8.A + 8.B)  Total number of voting rights held in issuer
 Resulting situation on the date on which threshold was crossed or reached  0.000000                                              0.972033                                                                   0.972033                        1107203
 Position of previous notification (if applicable)                          6.055482                                              1.003390                                                                   7.058872

8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached

8A. Voting rights attached to shares

 Class/Type of shares ISIN code(if possible)  Number of direct voting rights (DTR5.1)  Number of indirect voting rights (DTR5.2.1)  % of direct voting rights (DTR5.1)  % of indirect voting rights (DTR5.2.1)

 Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 Type of financial instrument  Expiration date  Exercise/conversion period  Number of voting rights that may be acquired if the instrument is  % of voting rights
                                                                            exercised/converted

 Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))

 Type of financial instrument  Expiration date  Exercise/conversion period  Physical or cash settlement  Number of voting rights  % of voting rights
 Swaps                         17/04/2024       N/A                         Cash                         437610                   0.384186
 Swaps                         31/07/2024       N/A                         Cash                         324556                   0.284933
 Swaps                         08/11/2024       N/A                         Cash                         20000                    0.017558
 Swaps                         02/12/2024       N/A                         Cash                         10000                    0.008779
 Swaps                         17/12/2024       N/A                         Cash                         236516                   0.207642
 Swaps                         18/12/2024       N/A                         Cash                         41053                    0.036041
 Swaps                         23/12/2024       N/A                         Cash                         33840                    0.029709
 Swaps                         30/12/2024       N/A                         Cash                         1745                     0.001532
 Swaps                         02/01/2025       N/A                         Cash                         1129                     0.000991
 Swaps                         03/02/2025       N/A                         Cash                         496                      0.000435
 Swaps                         04/02/2025       N/A                         Cash                         258                      0.000227
 Sub Total 8.B2                                                                                          1107203                  0.972033%

9. Information in relation to the person subject to the notification
obligation

2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)

 Ultimate controlling person  Name of controlled undertaking         % of voting rights if it equals or is higher than the notifiable threshold  % of voting rights through financial instruments if it equals or is higher  Total of both if it equals or is higher than the notifiable threshold
                                                                                                                                                 than the notifiable threshold
 Bank of America Corporation  Bank of America, National Association

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

17-Jan-2024

13. Place Of Completion

United Kingdom

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAQKFBKKBKDADD